Intravitreal bevacizumab (Avastin®) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis

Acta Ophthalmologica

Volumn 88, Issue 2, 2010, Pages

  Akesbi, Jad ^a   Brousseaud, François Xavier ^a   Adam, Raphaël ^a   Rodallec, Thibaud ^a   Nordmann, Jean Philippe ^a  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ANEURYSM; CASE REPORT; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IDIOPATHIC RETINITIS VASCULITIS ANEURYSM NEURORETINITIS SYNDROME; IRIS RUBEOSIS; LASER COAGULATION; LETTER; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA VASCULITIS; RETINITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

ANEURYSM; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MIDDLE AGED; RETINAL VASCULITIS; RETINAL VESSELS; RETINITIS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77649228025     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01540.x     Document Type: Letter

References (10)

1. Avery RL (2006 Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26 : 352 354.
2. Avery RL, Pearlman J, Pieramici DJ et al. (2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 : 1695 e1 1695 e15.
3. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH Caldwell RW (2003 Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes/metabolism research and reviews 19 : 442 455.
4. Chang TS, Aylward GW, Davis JL, Mieler WF, Oliver GL, Maberley AL Gass JD (1995 Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Retinal vasculitis study. Ophthalmology 102 : 1089 1097.
5. Guthoff R Goebel W (2008 Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis. Acta Ophthalmol [Epub ahead of print].
6. Jiang Y, Liang X, Li X, Tao Y Wang K (2008 Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy. Acta Ophthalmol [Epub ahead of print].
7. Kurup S, Lew J, Byrnes G, Yeh S, Nussenblatt R Levy-Clarke G (2009 Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization. Acta Ophthalmol 87 : 349 352.
8. McDonald HR (2003 Diagnostics and therapeutic challenges. IRVAN syndrome. Retina 23 : 392 399.
9. Samuel MA, Equi RA, Chang TS, Mieler W, Jampol LM, Hay D Yannuzzi LA (2007 Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology 114 : 1526 1529 e1.
10. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU Jorge R (2008 Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86 : 385 389.